全文获取类型
收费全文 | 10908篇 |
免费 | 631篇 |
国内免费 | 91篇 |
专业分类
耳鼻咽喉 | 84篇 |
儿科学 | 323篇 |
妇产科学 | 124篇 |
基础医学 | 1247篇 |
口腔科学 | 447篇 |
临床医学 | 962篇 |
内科学 | 2716篇 |
皮肤病学 | 281篇 |
神经病学 | 888篇 |
特种医学 | 533篇 |
外科学 | 1722篇 |
综合类 | 19篇 |
一般理论 | 1篇 |
预防医学 | 575篇 |
眼科学 | 94篇 |
药学 | 540篇 |
中国医学 | 21篇 |
肿瘤学 | 1053篇 |
出版年
2024年 | 20篇 |
2023年 | 139篇 |
2022年 | 240篇 |
2021年 | 451篇 |
2020年 | 220篇 |
2019年 | 350篇 |
2018年 | 431篇 |
2017年 | 284篇 |
2016年 | 298篇 |
2015年 | 326篇 |
2014年 | 434篇 |
2013年 | 514篇 |
2012年 | 732篇 |
2011年 | 789篇 |
2010年 | 445篇 |
2009年 | 421篇 |
2008年 | 656篇 |
2007年 | 640篇 |
2006年 | 597篇 |
2005年 | 604篇 |
2004年 | 542篇 |
2003年 | 492篇 |
2002年 | 397篇 |
2001年 | 190篇 |
2000年 | 166篇 |
1999年 | 141篇 |
1998年 | 82篇 |
1997年 | 78篇 |
1996年 | 63篇 |
1995年 | 57篇 |
1994年 | 47篇 |
1993年 | 42篇 |
1992年 | 83篇 |
1991年 | 65篇 |
1990年 | 65篇 |
1989年 | 63篇 |
1988年 | 52篇 |
1987年 | 44篇 |
1986年 | 39篇 |
1985年 | 31篇 |
1984年 | 26篇 |
1983年 | 32篇 |
1982年 | 21篇 |
1979年 | 18篇 |
1977年 | 19篇 |
1975年 | 17篇 |
1974年 | 20篇 |
1973年 | 18篇 |
1970年 | 13篇 |
1968年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
21.
22.
23.
L. Angrisani F. Favretti F. Furbetta L. Busetto S.B. Doldi E. Lattuada M. Paganelli M. Lucchese N. Basso F.D. Capizzi A. Iuppa G. Lesti N. Di Lorenzo C. Giardiello L. Di Cosmo A. Veneziani S. Lacitignola M. Alkilani P. Forestieri M. Toppino A. Gardinazzi F. Puglisi A. Cascardo P. Bernante G. Silecchia B. Marzano A. Adorni V. Borrelli M. Lorenzo 《Surgery for obesity and related diseases》2005,1(3)
24.
G. Fatati M. L. Amerio M. Bacci F. Brunetti A. Caretto L. Casali S. Coaccioli F. D’Andrea E. Del Toma M. Di Sapio D. Domeniconi M. Kob F. Leonardi E. Mirri P. Nanni A. Paci P. Pallini G. Ronzani A. R. Sabbatini S. G. Sukkar M. Tagliaferri G. Vincenzoni M. A. Fusco 《Mediterranean journal of nutrition and metabolism》2009,1(3):203-206
25.
Anna Di Landro Lorenzo Marchesi Luigi Naldi Teresio Motta Tullio Cainelli 《Pediatric dermatology》1997,14(6):449-452
Abstract: Hypopigmented mycosis fungoides is a variant of mycosis fungoides characterized by the presence of hypopigmented patches as the sole manifestation of the disease. It has been described aimost always in young black or dark-skinned patients. The only white patient described was a 64-year-oid woman who not oniy had hypopigmented lesions, but also nodular lesions with lymphadenopathy. We describe hypopigmented lesions arising in a white boy 12 years of age, born in northern Italy, without any foreign ancestors. The microscopic alterations, with epidermotropism, the immunoiogic markers, the negativity of T-cell receptor gene rearrangement, and the good response to PUVA therapy correspond to the main findings in black patients with this disease. Long-term follow-up of these patients is important to obtain better knowledge of the natural history of the disorder, Hypopigmented mycosis fungoides must now be included in the differential diagnosis of hypopigmented macular lesions not only in black or dark-skinned patients but also in white patients. 相似文献
26.
Lorenzo Melani Richard Mills David Hassman Robert Lipetz Leslie Lipka Alexandre LeBeaut Ramachandran Suresh Pabak Mukhopadhyay Enrico Veltri 《European heart journal》2003,24(8):717-728
AIMS: To evaluate the efficacy and safety of ezetimibe 10 mg administered with pravastatin in patients with primary hypercholesterolemia. METHODS AND RESULTS: After dietary stabilization, 2-12 week screening/washout period, and 4-week, single-blind, placebo lead-in period, 538 patients with baseline LDL-C > or =3.8 to < or =6.5 mmol/l and TG < or =4.0 mmol/l were randomized to one of eight possible treatments administered daily for 12 weeks: ezetimibe 10mg; pravastatin 10, 20, or 40 mg; ezetimibe 10 mg plus pravastatin 10, 20, or 40 mg; or placebo. The primary efficacy endpoint was percent reduction in LDL-C from baseline to study endpoint for ezetimibe 10 mg plus pravastatin (pooled doses) compared to pravastatin alone (pooled doses) and ezetimibe alone. The combined use of ezetimibe and pravastatin resulted in significant incremental reductions in LDL-C and TG compared to pooled pravastatin alone (p<0.01). Coadministration therapy reduced LDL-C by 34-41%, TG by 21-23%, and increased HDL-C by 7.8-8.4%, depending on the dose of pravastatin. The combined regimen was well tolerated, with a safety profile similar to pravastatin alone and placebo. CONCLUSIONS: When coadministered with pravastatin, ezetimibe provided significant incremental reductions in LDL-C and TG and was well tolerated with a safety profile similar to pravastatin alone. 相似文献
27.
During the early stages of nerve implantation, we followed the dynamic properties of the lateral gastrocnemius muscle of the rat, reinnervated with an acutely or chronically severed peroneal nerve. The aim of this study was to ascertain whether (1) the better functional recovery of a muscle reinnervated by a chronically severed foreign nerve is present from the onset of reinnervation, and (2) whether such functional improvement is due to the conditioning lesion effect. Our results indicate that better functional recovery is already apparent one week after nerve implantation, and it is due to the conditioning lesion effect, since tenotomy prevents such improvement. The tenotomy effect underlines the fact that some environmental factors concerning the target tissue, and not only the predegenerated nerve, are involved in the conditioning effect. © 1995 Wiley-Liss, Inc. 相似文献
28.
29.
Giovanni Melioli Editta Baldini Maria Cristina Mingari Andrea De Maria Mario Roberto Sertoli Fausto Badellino Pier Luigi Percivale Alessandra Catturich Sergio Bertoglio Dario Civalleri Leonardo Santi Lorenzo Moretta 《International journal of cancer. Journal international du cancer》1989,43(2):231-234
In the course of a phase I trial, in which recombinant IL-2 (rIL-2) was infused intraperitoneally (i.p.) in patients with peritoneal carcinomatosis, we evaluated the effect on "tumor-associated lymphocytes" (TAL) isolated from the ascitic fluid. No major changes in the percentages of cells expressing the CD3, CD4, CD8, Leu-7, OKM1 and WT-31 antigens were detected either in TAL or in peripheral blood lymphocytes (PBL) after 7 days of rIL-2 infusion. In contrast the percentages of TAL (but not PBL) expressing surface IL-2 receptor (Tac), or LAK-1 antigen were sharply increased. Analysis of cytolytic functions showed a potentiation of the lytic activity against natural-killer (NK) sensitive K562 target cells and the de novo appearance of lytic activity against fresh melanoma cells. In one patient IFN-gamma was detected in the ascitic fluid following rIL-2 infusion. T-cell clones derived from the patient were analyzed for the IFN-gamma production. While only approximately 40% of PB-derived control clones produced medium to low amounts of IFN-gamma, all of the TAL-derived clones produced medium to high amounts of the lymphokine. 相似文献
30.
Lorenzo Moretta Maria Cristina Mingari Daniela Pende Cristina Bottino Roberto Biassoni Alessandro Moretta 《Journal of clinical immunology》1996,16(5):243-253
Natural Killer cells are likely to play an important role in the host defenses because they kill virally infected or tumor cells but spare normal self-cells. The molecular mechanism that explains why NK cells do not kill indiscriminately has recently been elucidated. It is due to several specialized receptors that recognize major histocompatibility complex (MHC) class I molecules expressed on normal cells. The lack of expression of one or more HLA class I alleles leads to NK-mediated target cell lysis. Different types of receptors specific for groups of HLA-C, HLA-B, and, very recently, HLA-A alleles have been identified. While in most instances, they function as inhibitory receptors, an activatory form of the HLA-C-specific receptors has been identified in some donors. Molecular cloning of HLA-C-, HLA-B- or HLA-A-specific receptors has revealed new members of the immunoglobulin superfamily with two or three Ig-like domains, respectively, in their extracellular portion. While the inhibitory form is characterized by a long cytoplasmic tail associated with a non-polar transmembrane portion, the activatory one has a short tail asociated with a Lys-containing transmembrane portion. Thus, these human NK receptors are different from the murine Ly49, that is a type II transmembrane protein characterized by a C-type lectin domain. A subset of activated T lymphocytes expresses NK-type class I-specific receptors. These receptors exert an inhibiting activity on T cell receptor-mediated functions and may provide an important mechanism of downregulation of T cell responses. 相似文献